SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?

To: VLAD who wrote (19139)2/27/1999 6:33:00 PM
From: AlienTech  Read Replies (1) | Respond to of 23519
 
>>I think that maybe we can make some good comparisson of how AKLM was able to recover with time and don't forget that with diluted shares and earnings of only 37 cents one year trailing they managed to trade from 3 to 13. I believe that based what I know about Vivus and what I knew about AKLM that Vivus has an even better chance of recovery that what AKLM has done.<<

Yea but when did AKLM have a huge short position agenda in it?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News